Notice of Meeting, 13135-13136 [2010-5682]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Medical Liability
and Safety Innovation Projects (R21)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Medical Liability and
Safety Innovation Projects (R2l)
Date: April 2, 2010 (Open on April 2 from
8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting)
Place: Doubletree Bethesda Hotel &
Executive Meeting Center, 8120 Wisconsin
Avenue, Conference Room TBD, Bethesda,
Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
This notice is published less than 15 days
in advance of the meeting date due to
logistical difficulties.
sroberts on DSKD5P82C1PROD with NOTICES
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–5744 Filed 3–17–10; 8:45 am]
BILLING CODE 4160–90–M
VerDate Nov<24>2008
17:08 Mar 17, 2010
Jkt 220001
13135
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
Agency for Healthcare Research and
Quality
[FR Doc. 2010–5698 Filed 3–17–10; 8:45 am]
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Medical Liability
and Safety Demonstration Projects (R18)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Medical Liability and
Safety Demonstration Projects (R18).
Date: March 31–April 1, 2010 (Open on
March 31 from 8 a.m. to 8:15 a.m. and closed
for the remainder of the meeting).
Place: Doubletree Bethesda Hotel &
Executive Meeting Center, 8120 Wisconsin
Avenue, Conference Room TBD, Bethesda,
Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
This notice is published less than 15 days
in advance of the meeting date due to
logistical difficulties.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the OS ARRA:
Expansion of Research Capabilities to
Study CE Complex Patients (R24)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: OS ARRA: Expansion of
Research Capabilities to Study CE Complex
Patients (R24).
Date: April 5–6, 2010 (Open on April 5
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
Place: Bethesda North Marriott, 5701
Marinelli Road, Conference Room TBD,
Bethesda, Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
E:\FR\FM\18MRN1.SGM
18MRN1
13136
Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices
Agenda items for this meeting are subject
to change as priorities dictate.
This notice is published less than 15 days
in advance of the meeting date due to
logistical difficulties.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
National Institute on Drug Abuse;
Notice of Closed Meeting
[FR Doc. 2010–5682 Filed 3–17–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
sroberts on DSKD5P82C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biomedical Library
and Informatics Review Committee.
Date: June 10–11, 2010.
Time: June 10, 2010, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Time: June 11, 2010, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Arthur A. Petrosian, PhD,
Chief Scientific Review Officer, Division of
Extramural Programs, National Library of
Medicine, 6705 Rockledge Drive, Suite 301,
Bethesda, MD 20892–7968, 301–496–4253,
petrosia@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: March 9, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5680 Filed 3–17–10; 8:45 am]
BILLING CODE 4140–01–M
VerDate Nov<24>2008
17:08 Mar 17, 2010
Jkt 220001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Loan
Repayment.
Date: March 22, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Virtual Meeting)
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH.
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 9, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5678 Filed 3–17–10; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
Regents of the National Library of
Medicine.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Regents of
the National Library of Medicine;
Subcommittee on Outreach and Public
Information.
Date: May 11, 2010.
Time: 7:30 a.m. to 8:45 a.m.
Agenda: Outreach Activities.
Place: National Library of Medicine,
Building 38, 2nd Floor, Conference Room B,
8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library Of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine.
Date: May 11–12, 2010.
Open: May 11, 2010, 9 a.m. to 4:30 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: May 11, 2010, 4:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Open: May 12, 2010, 9 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 75, Number 52 (Thursday, March 18, 2010)]
[Notices]
[Pages 13135-13136]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5682]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the OS ARRA: Expansion of Research
Capabilities to Study CE Complex Patients (R24) applications are to be
reviewed and discussed at this meeting. These discussions are likely to
reveal personal information concerning individuals associated with the
applications. This information is exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: OS ARRA: Expansion of Research Capabilities to
Study CE Complex Patients (R24).
Date: April 5-6, 2010 (Open on April 5 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting).
Place: Bethesda North Marriott, 5701 Marinelli Road, Conference
Room TBD, Bethesda, Maryland 20852.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
[[Page 13136]]
Agenda items for this meeting are subject to change as
priorities dictate.
This notice is published less than 15 days in advance of the
meeting date due to logistical difficulties.
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-5682 Filed 3-17-10; 8:45 am]
BILLING CODE 4160-90-M
